Segment Results (Schedule Of Reportable Segments Information) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2017 USD ($) segment	Mar. 31, 2016 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment	3
Segment Reporting Information [Line Items]
Total net revenues to external customers	$ 1,037,600	$ 963,539
Total segment adjusted income from continuing operations before income tax	485,973	402,303
U.S. Generic Pharmaceuticals
Segment Reporting Information [Line Items]
Total net revenues to external customers	721,983	583,390
Total segment adjusted income from continuing operations before income tax	341,599	211,768
U.S. Branded Pharmaceuticals
Segment Reporting Information [Line Items]
Total net revenues to external customers	250,159	308,813
Total segment adjusted income from continuing operations before income tax	129,492	168,781
International Pharmaceuticals
Segment Reporting Information [Line Items]
Total net revenues to external customers	65,458	71,336
Total segment adjusted income from continuing operations before income tax	$ 14,882	$ 21,754